A Pilot Trial of Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With DLBCL
Phase of Trial: Phase I
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Blinatumomab (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 02 Aug 2017 Status changed from not yet recruiting to recruiting.
- 17 Jul 2017 Planned End Date changed from 31 Jul 2021 to 30 Sep 2021.
- 17 Jul 2017 Planned primary completion date changed from 30 Nov 2018 to 31 Jan 2019.